The effect of ursodeoxycholic acid on serum enzymes and liver histology in patients with chronic active hepatitis. A 12-month double-blind, placebo-controlled trial

Journal of Hepatology

Volumn 20, Issue 3, 1994, Pages 315-320

  Attili, Adolpo Francesco ^a   Rusticali, Annabiulia ^a   Varriale, Maria ^b   Carli, Laura ^b   Repice, Anna Maria ^b   Callea, Francesco ^c  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HISTOLOGY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; DOUBLE-BLIND METHOD; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; TRANSFERASES; URSODEOXYCHOLIC ACID;

EID: 0028326265     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(94)80001-4     Document Type: Article

References (30)

1. Clinical experience with ursodeoxycholic acid (S-Urso) for chronic hepatitis
2. Effect of Ursosan tablets on chronic hepatic disorders
3. Effectiveness of S-Urso tablet against chronic liver diseases
4. Effect of ursodeoxycholic acid on liver function of chronic liver disease
5. Study of curative effect of ursodeoxycholic acid for chronic hepatitis by double-blind trial
6. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up A pilot study
7. Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids
8. Reduction in serum transaminases during taurine administration in patients with chronic active hepatitis
9. Ursodeoxycholic acid for chronic liver disease
10. Effects of ursodeoxycholate, taurine and ursodeoxycholate plus taurine on serum enzyme levels in patients with chronic hepatitis
11. Long-term administration of ursodeoxycholic acid in patients with chronic hepatitis. A comparison of the effect of two doses on liver function
12. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
13. The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study
14. Mechanisms of action of ursodeoxycholic acid in the treatment of chronic cholestatic hepatobiliary disease: experiments and speculations
15. Hepatic expression of HLA molecules in primary biliary cirrhosis the effect of ursodeoxycholic acid
16. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid
17. 3 excretion
18. Effect of taurochenodeoxycholate and tauroursodeoxycholate upon biliary output of phospholipids and plasma membrane enzymes, and the extent of cell damage, in isolated perfused rat livers
19. Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes
20. Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat
21. Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties. Studies on isolated hepatocytes and lipid membrane vesicles
22. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial
23. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled doubleblind trial
24. A randomised controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
25. Ursodeoxycholic acid in primary biliary cirrhosis
26. Ursodesoxycholsaure bei primar biliarer Zirrhose. Teil 2: prospektive Langzeitstudie an 21 Patienten
27. Ursodeoxycholic acid treatment for chronic cholestatic liver disease
28. Ursodeoxycholic acid for primary sclerosing cholangitis